Rasburicase Uses, Side Effects & Warnings - Drugs.com
2024年1月22日 · Rasburicase is used to manage uric acid levels in adults and children receiving cancer treatment for leukemia, lymphoma, and certain tumors. Rasburicase may also be used …
Rasburicase - Wikipedia
Rasburicase, sold under the brand name Elitek in the US and Fasturtec in the EU, is a medication that helps to clear uric acid from the blood. It is a recombinant version of urate oxidase, an enzyme that metabolizes uric acid to allantoin.
Rasburicase (intravenous route) - Mayo Clinic
2024年1月31日 · Rasburicase injection treats high uric acid blood levels (hyperuricemia) that are caused by cancer treatment. This medicine is used in adults and children with certain types of cancer (e.g., leukemia, lymphoma, or solid tumors).
ELITEK® (rasburicase) for injection, for intravenous use ... - Sanofi
Elitek is a recombinant urate-oxidase indicated for initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anticancer therapy expected to result in tumor lysis and subsequent elevation of …
Rasburicase Injection: MedlinePlus Drug Information
Rasburicase injection is used to treat high levels of uric acid (a natural substance that builds up in the blood as tumors break down) in people with certain types of cancer who are being treated with chemotherapy medications. Rasburicase injection is in a class of medications called enzymes.
Elitek (rasburicase) dosing, indications, interactions, adverse …
Medscape - Indication-specific dosing for Elitek (rasburicase), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...
Rasburicase Advanced Patient Information - Drugs.com
2024年5月22日 · Rasburicase injection treats high uric acid blood levels (hyperuricemia) that are caused by cancer treatment. This medicine is used in adults and children with certain types of …
Rasburicase - NCI - National Cancer Institute
Rasburicase is approved to treat adults and children with: High levels of uric acid in the blood. Rasburicase is also approved to prevent: Tumor lysis syndrome in adults and children with leukemia, lymphoma, or malignant solid tumors. It is used when the treatment is expected to cause high blood levels of uric acid.
Rasburicase Solution, Reconstituted (Recon Soln) - WebMD
Find patient medical information for rasburicase intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Rasburicase: Dosage, Mechanism/Onset of Action, Half-Life
2020年2月10日 · Rasburicase is a recombinant urate-oxidase enzyme, which converts uric acid to allantoin (an inactive and soluble metabolite of uric acid); it does not inhibit the formation of uric acid. Pediatric patients: 110 to 127 mL/kg; Adults: 76 to 138 mL/kg. Uric acid levels decrease within 4 hours of initial administration. ~16 to 23 hours.